The capital markets are no stranger to dramatic turns, and the latest protagonist is Estun Automation Co., Ltd. (SZSE: 002747), often referred to as the "first listed industrial robotics company." On the evening of July 14th, Estun released what appeared to be a stellar preliminary financial report for the first half of 2026: it expects net profit attributable to shareholders to reach 1.5 to 1.8 billion yuan, a staggering year-on-year surge of 2,144.74% to 2,593.68%. Non-GAAP net profit is forecasted to be between 600 million and 750 million yuan, turning a profit compared to a loss in the same period last year. The following trading day, July 15th, its stock price jumped 6.51% to close at 40.9 yuan.
However, this positive momentum was short-lived. On July 17th and July 20th, Estun's stock price hit the daily downside limit in two consecutive sessions, plunging to 34.37 yuan, with its total market capitalization shrinking to approximately 333 billion yuan. With profits reportedly soaring over twentyfold, why did the stock suffer such heavy selling?
Unpacking the Profit Surge: An Accounting Anomaly
The astonishing profit growth forecasted by Estun does not stem from a breakout performance in its core operations. Instead, it is largely attributed to a non-recurring gain of 865.362 million yuan recognized in the first quarter from changes in fair value. This gain originated from the company swapping its 3% stake in a non-listed associate, Nanjing Process, for shares in the listed company Nanjing Chemical Fibre Co., Ltd. According to accounting rules, this equity swap triggered a significant fair value revaluation gain, which was directly booked into current period profits.
This one-time gain had a decisive, distorting effect on the income statement. In Q1 2026, Estun reported a net profit attributable to shareholders of 978.367 million yuan, a 674.64% year-on-year increase. However, after stripping out this 865.362 million yuan non-recurring item, its non-GAAP net profit was only 193.586 million yuan. This means that over 88% of the company's Q1 net profit came from this non-sustainable accounting treatment.
Looking at the quarterly progression, with Q1 profit already at 978.367 million yuan, the implied Q2 profit is only between 52 million and 82 million yuan, representing a sequential decline of 16% to 46%. The so-called "profit rocket," upon closer inspection, shows its thrust is already diminishing. The market is well aware of this. Investors buy into future growth expectations, not one-off asset revaluations. When the "quality" of profits is significantly diluted, the market naturally re-evaluates the company's valuation.
Underlying Business Concerns: Revenue Stagnation and Cash Flow Worries
Setting aside the noise from non-recurring items, the fundamentals of Estun's core business are far less rosy than the headline numbers suggest, revealing several underlying risks.
Firstly, revenue growth has stalled. In Q1 2026, the company's total operating revenue was 12.17 billion yuan, a slight year-on-year decrease of 2.22%. This contrasts sharply with the 21.93% revenue growth for the full year 2025, indicating that the growth engine of its core business is losing steam. Amid intensifying competition in the industrial robotics sector, Estun, as the volume leader, has failed to effectively translate its market share advantage into revenue growth, facing severe tests to its market position and pricing power.
Secondly, and most concerning, is the severe divergence between operating cash flow and reported profits, highlighting "paper prosperity." In Q1 2026, despite reporting a net profit nearing 1 billion yuan, the net cash flow from operating activities was negative 1.47 billion yuan. Compared to a net inflow of 475.225 million yuan in the same period last year, this represents a deterioration of over 400%. Profit is on paper, cash flow is real money. A company can survive without profits for a while, but not without cash flow. This significant divergence exposes major issues with the quality of its earnings.
The company attributed the cash flow deterioration to "increased orders and production, leading to a 33.96% year-on-year increase in cash paid for goods and services." However, the deeper reasons lie elsewhere: a sharp increase in accounts receivable and declining collection efficiency. As of the end of Q1 2026, the company's accounts receivable and notes stood at 21.27 billion yuan while revenue was declining. The days sales outstanding (DSO) lengthened to 148.54 days from 132.20 days a year earlier. Concurrently, credit impairment losses surged 210.62% year-on-year. This suggests that to maintain sales, the company may have relaxed its credit policies, resulting in a large portion of revenue remaining as book entries and accumulating bad debt risk. Furthermore, inventory remains high at 13.75 billion yuan, tying up significant working capital.
Thirdly, goodwill remains a long-term risk. As of the end of 2025, goodwill still stood at 10.3 billion yuan, accounting for over half of net assets, primarily from the acquisition of Germany's Cloos. Cloos reported a net profit of only 12 million yuan in 2025, indicating an extremely low return on assets and posing a constant risk of impairment.
Fourthly, there is a structural divide in profitability, with fierce competition in the domestic market. The 2025 annual report reveals a clear structural issue in Estun's profitability. The gross margin for its domestic business was 26.33%, down 1.63 percentage points year-on-year, while the gross margin for its overseas business was as high as 36.75%, up 4.09 percentage points. This clearly indicates that the company's "number one in shipment volume" position in China is likely achieved at the expense of profitability. The domestic industrial robotics market has entered a stage of competition for existing customers, with price wars intensifying and severely eroding profit margins. In contrast, the faster-growing overseas business (29.79% growth) has a much lower growth rate (6.80%) for its more profitable segment, showing that the pace of global expansion has not kept up with the intense competition domestically.
Stock Price Perspective: A Market Correction
Firstly, a correction after a sharp rally is a fundamental market principle. Since June, fueled by themes like Tesla's Optimus production, Unitree's IPO, and humanoid robotics, Estun's stock logged six daily upside limit sessions within a month. On July 8th, it briefly hit the downside limit intraday, while its H-shares plummeted over 16% that day, with its price-to-earnings (P/E) ratio once soaring above 900 times. The release of the earnings forecast provided a perfect window for profit-taking as "good news was sold."
Secondly, the capital flow structure tells the story. On July 14th, the day of the forecast, net outflows from major funds amounted to 102 million yuan. On July 17th, the first limit-down day, net outflows from major funds hit 313 million yuan, while retail investors saw net inflows of 338 million yuan—a clear script of institutional distribution and retail buying. The turnover rate in the preceding week was as high as 92.12%, indicating that shareholding had already become unstable.
Thirdly, there is pressure for the A/H share premium to converge. The company completed its H-share listing in March. The A-share to H-share price ratio once reached as high as 2.59 times, leaving A-share valuation suspended at a high level. Convergence towards the H-share price is a likely scenario. Additionally, the company's plan to acquire the remaining equity in the consistently loss-making Estun Cloos, pending regulatory approval, adds further uncertainty.
Reassessing Expectations, Not Just Fundamentals
Objectively speaking, the forecast is not without its merits: a significant improvement in overall gross margin, a decline in period expense ratios, and a return to profitability on a non-GAAP basis indicate that measures focused on high-value orders and cost efficiency since 2025 are taking effect. Following the receipt of 12.83 billion yuan from the H-share fundraising, the asset-liability ratio dropped from over 82% to 69.18%, significantly bolstering the financial safety cushion. The company's industrial robot shipments surpassed those of foreign brands for the first time in 2025, topping the Chinese market, confirming its genuine leading position.
The problem lies in the fact that the stock price is no longer pricing in fundamentals alone, but also market sentiment. With a market cap of around 333 billion yuan, corresponding to an annualized non-GAAP profit of less than 2 billion yuan and a P/E ratio well over 100 times, continued delivery on the narratives of humanoid robotics and embodied intelligence is needed to justify such valuations. When the interim report is officially disclosed on August 22nd, investors should focus on four key indicators: whether revenue can return to growth, whether non-GAAP profits can be sustained, whether operating cash flow turns positive, and whether risks from receivables and goodwill are contained.
The forecasted growth of 2,144.74% to 2,593.68% represents the report card for a turnaround over the past six months. The two consecutive limit-down sessions, however, represent the bill presented by the market for "overstretched expectations." For the company, it may be a positive development in the long run. For investors who bought at the peak, it serves as a lesson in risk management.
Comments